Age-related (type II) femoral neck osteoporosis in men: Biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption

被引:95
作者
Boonen, S
Vanderschueren, D
Cheng, XG
Verbeke, G
Dequeker, J
Geusens, P
Broos, P
Bouillon, R
机构
[1] KATHOLIEKE UNIV LEUVEN,ARTHRIT & METAB BONE DIS RES UNIT,B-3001 LOUVAIN,BELGIUM
[2] KATHOLIEKE UNIV LEUVEN,LAB EXPT MED & ENDOCRINOL,B-3001 LOUVAIN,BELGIUM
[3] KATHOLIEKE UNIV LEUVEN,CTR BIOSTAT,DEPT EPIDEMIOL,B-3001 LOUVAIN,BELGIUM
[4] KATHOLIEKE UNIV LEUVEN,DEPT TRAUMATOL & EMERGENCY SURG,B-3001 LOUVAIN,BELGIUM
关键词
D O I
10.1359/jbmr.1997.12.12.2119
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The problem of osteoporosis in men has recently been recognized as an important public health issue, To test the hypothesis that endocrine deficiency-mediated alterations in bone metabolism might contribute to osteoporotic fracture risk in elderly men, serum levels of 25-hydroxycholecalciferol (25(OH)D), 1,25-dihydroxycholecalciferol (1,25(OH)(2)D), intact parathyroid hormone (PTH), testosterone, and estradiol were measured in 40 males (mean age 73 years) who were consecutively recruited within 18 h following a fracture of the proximal femur, and in an equal number of community-living older men (mean age 72 years) who served as controls, In addition, circulating osteocalcin and urinary excretion of (deoxy)pyridinoline were determined as markers of bone formation and resorption, respectively, No differences were observed between the mean serum concentrations of osteocalcin and estradiol, Serum levels of 25(OH)D, 1,25(OH)(2)D, and testosterone, however, were decreased in hip fracture patients, When correcting for differences in vitamin D binding protein, differences in 1,25(OH)(2)D did not persist, whereas serum 25(OH)D was still significantly lower in patients than in controls (6.1 +/- 4.3 vs, 7.6 +/- 2.8, p = 0.01), Similarly, a highly significant deficit was observed in the free testosterone index, calculated from total testosterone and the level of sex hormone binding globulin (2.6 +/- 1.3 vs, 8.2 +/- 2.9, p < 0.001), Serum PTH and urinary pyridinium cross-links, however, were markedly increased in the fracture group, Moreover, in fracture patients, free 25(OH)D and free testosterone were both significant and mutually independent negative predictors of (deoxy)pyridinoline excretion, Although limited by its cross-sectional design, the present study suggests that both hypovitaminosis D and androgen deficiency may predispose to hone resorption in elderly men and in turn to remodeling imbalance and fracture risk.
引用
收藏
页码:2119 / 2126
页数:8
相关论文
共 68 条
[1]
ABASSI AA, 1993, J AM GERIATR SOC, V41, P975
[2]
IMPAIRMENT OF BONE TURNOVER IN ELDERLY WOMEN WITH HIP FRACTURE [J].
AKESSON, K ;
VERGNAUD, P ;
GINEYTS, E ;
DELMAS, PD ;
OBRANT, KJ .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (03) :162-169
[3]
Dehydroepiandrosterone (DHEA): A fountain of youth? [J].
Baulieu, EE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3147-3151
[4]
CALCIOTROPIC HORMONES IN ELDERLY PEOPLE WITH AND WITHOUT HIP FRACTURE [J].
BENHAMOU, CL ;
TOURLIERE, D ;
GAUVAIN, JB ;
PICAPER, G ;
AUDRAN, M ;
JALLET, P .
OSTEOPOROSIS INTERNATIONAL, 1995, 5 (02) :103-107
[5]
REGULATION OF C-FOS EXPRESSION AND TGF-BETA PRODUCTION BY GONADAL AND ADRENAL ANDROGENS IN NORMAL HUMAN OSTEOBLASTIC CELLS [J].
BODINE, PVN ;
RIGGS, BL ;
SPELSBERG, TC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (02) :149-158
[6]
Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: Potential implications for the prevention of age-related bone loss [J].
Boonen, S ;
Lesaffre, E ;
Dequeker, J ;
Nijs, J ;
Pelemans, W ;
Bouillon, R .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (11) :1301-1306
[7]
INFLUENCE OF THE VITAMIN-D-BINDING PROTEIN ON THE SERUM CONCENTRATION OF 1,25-DIHYDROXYVITAMIN-D3 - SIGNIFICANCE OF THE FREE 1,25-DIHYDROXYVITAMIN-D3 CONCENTRATION [J].
BOUILLON, R ;
VANASSCHE, FA ;
VANBAELEN, H ;
HEYNS, W ;
DEMOOR, P .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (03) :589-596
[8]
BOUILLON R, 1992, CLIN CHEM, V38, P2055
[9]
BOUILLON R, 1980, CLIN CHEM, V26, P562
[10]
BOUILLON R, 1976, CLIN CHEM, V22, P364